Nurulimab

Tax included
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) humanized monoclonal antibody. Nurulimab can be can be used in research of melanoma.
MedChemExpress 
HY-P99760

Data sheet

Size
Multiple sizes
Reactivity
CTLA-4
CAS
2168561-20-2